Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women

Prummel, 1991, The course of biochemical parameters of bone turnover during treatment with corticosteroids, J Clin Endocrinol Metab., 72, 382, 10.1210/jcem-72-2-382 Saag, 2007, Teriparatide or alendronate in glucocorticoid-induced osteoporosis, N Engl J Med., 357, 2028, 10.1056/NEJMoa071408 Manelli, 2002, Growth hormone in glucocorticoid-induced osteoporosis, Front Horm Res., 30, 174, 10.1159/000061083 Wang, 2007, Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor, J Mol Endocrinol., 38, 467, 10.1677/jme.1.02173 Fujikawa, 1997, Steroid sulfatase activity in osteoblast cells, Biochem Biophys Res Commun., 231, 42, 10.1006/bbrc.1996.6038 Bodine, 1995, Regulation of c-fos expression and TGF-beta production by gonadal and adrenal androgens in normal human osteoblastic cells, J Steroid Biochem Mol Biol., 52, 149, 10.1016/0960-0760(94)00165-I Purohit, 1992, Estrogen synthesis by osteoblast cell lines, Endocrinology., 131, 2027, 10.1210/endo.131.4.1396346 Nawata, 1995, Aromatase in bone cell: association with osteoporosis in postmenopausal women, J Steroid Biochem Mol Biol., 53, 165, 10.1016/0960-0760(95)00031-T Szathmári, 1994, Dehydroepiandrosterone sulphate and bone mineral density, Osteoporos Int., 4, 84, 10.1007/BF01623229 Formiga, 1997, The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus, Clin Exp Rheumatol., 15, 387 Sambrook, 1992, Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens, J Rheumatol., 19, 357 Turner, 1990, Dehydroepiandrosterone reduces cancellous bone osteopenia in ovariectomized rats, Am J Physiol., 258, E673 Devogelaer, 1987, Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass, Br Med J (Clin Res Ed)., 294, 798, 10.1136/bmj.294.6575.798 Papierska, 2000, Wpływ leczenia preparatem “Gynodian” na gęstość mineralną kości u pacjentek z niewydolnością kory nadnerczy [Effect of Gynodian injections on bone mineral density in female patients with Addison's disease], Endokrynol Pol., 51, 297 Gurnell, 2008, Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial, J Clin Endocrinol Metab., 93, 400, 10.1210/jc.2007-1134 Diamond, 1996, Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women, J Endocrinol., 150, S43 Sun, 2002, Treatment of osteoporosis in men using dehydroepiandrosterone sulfate, Chin Med J (Engl)., 115, 402 Kahn, 2002, Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men, J Clin Endocrinol Metab., 87, 1544, 10.1210/jcem.87.4.8396 Jankowski, 2006, Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial, J Clin Endocrinol Metab., 91, 2986, 10.1210/jc.2005-2484 Jankowski, 2008, Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens, J Clin Endocrinol Metab., 93, 4767, 10.1210/jc.2007-2614 van Vollenhoven, 1998, Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months, J Rheumatol., 25, 285 Eastell, 1998, A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update, J Intern Med., 244, 271, 10.1046/j.1365-2796.1998.00408.x Legrain, 2000, Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects, J Clin Endocrinol Metab., 85, 3208 Arlt, 1999, Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens, J Clin Endocrinol Metab., 84, 2170, 10.1210/jcem.84.6.5789 Arlt, 1998, Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression, J Clin Endocrinol Metab., 83, 1928, 10.1210/jcem.83.6.4850 Bruder, 1997, Dehydroepiandrosterone stimulates the estrogen response element, J Steroid Biochem Mol Biol., 62, 461, 10.1016/S0960-0760(97)00056-3 Chen, 2005, Direct agonist/antagonist functions of dehydroepiandrosterone, Endocrinology., 146, 4568, 10.1210/en.2005-0368 Yakar, 2002, Circulating levels of IGF-1 directly regulate bone growth and density, J Clin Invest., 110, 771, 10.1172/JCI0215463 Casson, 1998, Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial, Fertil Steril., 70, 107, 10.1016/S0015-0282(98)00121-6 Villareal, 2000, Effects of DHEA replacement on bone mineral density and body composition in elderly women and men, Clin Endocrinol (Oxf)., 53, 561, 10.1046/j.1365-2265.2000.01131.x Johannsson, 2002, Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial, J Clin Endocrinol Metab., 87, 2046, 10.1210/jcem.87.5.8494 Arlt, 1999, Dehydroepiandrosterone replacement in women with adrenal insufficiency, N Engl J Med., 341, 1013, 10.1056/NEJM199909303411401 Delany, 2001, Glucocorticoid suppression of IGF I transcription in osteoblasts, Mol Endocrinol., 15, 1781, 10.1210/mend.15.10.0704 Haden, 2000, Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women, Calcif Tissue Int., 66, 414, 10.1007/s002230010084 Clemmons, 1992, Role of insulin-like growth factor-1 in reversing catabolism, J Clin Endocrinol Metab., 75, 1183 Delany, 2002, The cellular and molecular basis of glucocorticoid actions in bone, Front Horm Res., 30, 2, 10.1159/000061068 Bruyere, 2002, Biochemical markers in glucocorticoid-induced osteoporosis, Front Horm Res., 30, 49, 10.1159/000061072 Bouvard, 2010, Glucocorticoid-Induced Osteoporosis: A Review, Clinic Rev Bone Miner Metab., 8, 15, 10.1007/s12018-009-9051-9 Robinzon, 1999, Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?, Rheumatology (Oxford)., 38, 488, 10.1093/rheumatology/38.6.488